Short Interest in Nicox SA (OTCMKTS:NICXF) Drops By 99.9%

Nicox SA (OTCMKTS:NICXF) saw a significant decrease in short interest in the month of February. As of February 27th, there was short interest totaling 21 shares, a decrease of 99.9% from the February 12th total of 20,021 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Approximately 0.0% of the shares of the company are sold short.

Nicox Price Performance

OTCMKTS:NICXF opened at $0.30 on Thursday. Nicox has a 12 month low of $0.25 and a 12 month high of $0.30. The company has a 50 day simple moving average of $0.30 and a two-hundred day simple moving average of $0.30.

Nicox Company Profile

Nicox is a global biopharmaceutical company focused on the research, development and commercialization of innovative treatments for eye diseases. The company’s therapeutic approach centers on nitric oxide–donating compounds and anti-inflammatory agents designed to address glaucoma, ocular surface disorders and allergic eye conditions. With a pipeline spanning pre-clinical to late-stage clinical programs, Nicox aims to bring new modalities to market that target unmet needs in ophthalmology.

The company’s lead commercial product, ZERVIATE® (ciclesonide ophthalmic solution), is indicated for the relief of ocular itching associated with allergic conjunctivitis.